| 2221 |
|
CUTTING EDGE - Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection/
|
Takeuchi, Osamu
|
Williams & Wilkins
|
2000
|
|
|
|
| 2222 |
|
CUTTING EDGE - Cutting Edge: Two Distinct Mechanisms Lead to Impaired T Cell Homeostasis in Janus Kinase 3- and CTLA-4-Deficient Mice/
|
Gozalo-Sanmillan, Sara
|
Williams & Wilkins
|
2001
|
|
|
|
| 2223 |
|
CUTTING EDGE - Neutrophil FcgRI as Target for Immunotherapy of Invasive Candidiasis/
|
Spriel, Annemiek B van
|
Williams & Wilkins
|
2001
|
|
|
|
| 2224 |
|
Cybersurveillance Without Restraint? The Meaning and Social Value of the Probable Cause and Reasonable Suspicion Standards in Governmental Access to Third-Party Electronic Records
|
Taslitz, A.E.
|
Williams & Wilkins
|
2013
|
|
|
|
| 2225 |
|
Cyclin D3 Immunoreactivity in Gastrointestinal Stromal Tumors Is Independent of Cyclin D3 Gene Amplification and Is Associated with Nuclear p27 Accumulation/
|
Pruneri, G
|
Williams & Wilkins
|
2003
|
|
|
|
| 2226 |
|
Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: Evidence for Akt inhibition in celecoxib-induced apoptosis/
|
Leng, J
|
Williams & Wilkins
|
2003
|
|
|
|
| 2227 |
|
Cyclooxygenase Isozymes Involved in Adaptive Functional Responses in Rat Stomach after Barrier Disruption/
|
Takeeda, M
|
Williams & Wilkins
|
2003
|
|
|
|
| 2228 |
|
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes/
|
Watashi, K
|
Williams & Wilkins
|
2003
|
|
|
|
| 2229 |
|
Cyclosporine Induces Progressive Attenuation of Baroreceptor Heart Rate Response and Cumulative Pressor Response in Conscious Unrestrained Rats/
|
Shaltout, H. A
|
Williams & Wilkins
|
2003
|
|
|
|
| 2230 |
|
CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease/
|
Emery, M. G
|
Williams & Wilkins
|
2003
|
|
|
|
| 2231 |
|
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug-Induced Hepatitis/
|
Huang, Y.-S
|
Williams & Wilkins
|
2003
|
|
|
|
| 2232 |
|
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E/
|
Kugelmas, M
|
Williams & Wilkins
|
2003
|
|
|
|
| 2233 |
|
Cytosolic Ca^2^+and Phosphoinositide Hydrolysis Linked to Constitutively Active alpha~1~D-Adrenoceptors in Vascular Smooth Muscle/
|
Gisbert, R
|
Williams & Wilkins
|
2003
|
|
|
|
| 2234 |
|
Cytotoxicity, DNA Damage, and Apoptosis Induced by New Fotemustine Analogs on Human Melanoma Cells in Relation to O^6-Methylguanine DNA-Methyltransferase Expression/
|
Passagne, I
|
Williams & Wilkins
|
2003
|
|
|
|
| 2235 |
|
The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio/
|
Solinas, M
|
Williams & Wilkins
|
2003
|
|
|
|
| 2236 |
|
The CE Mark/
|
Hakelius, L
|
Williams & Wilkins
|
2003
|
|
|
|
| 2237 |
|
The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development/
|
Terry, A. V
|
Williams & Wilkins
|
2003
|
|
|
|
| 2238 |
|
The Competitive N-Methyl-D-aspartate Receptor Antagonist (-)-6-Phosphonomethyl-deca-hydroisoquinoline-3-carboxylic Acid (LY235959) Potentiates the Antinociceptive Effects of Opioids That Vary in Efficacy at the mu-Opioid Receptor/
|
Allen, R. M
|
Williams & Wilkins
|
2003
|
|
|
|
| 2239 |
|
The Complex Triplane Fracture: Ipsilateral Tibial Shaft and Distal Triplane Fracture/
|
Jarvis, James G
|
Williams & Wilkins
|
2001
|
|
|
|
| 2240 |
|
The Concept of Fillet Flaps: Classification, Indications, and Analysis of Their Clinical Value/
|
K�ntscher, Markus V
|
Williams & Wilkins
|
2001
|
|
|
|